193 related articles for article (PubMed ID: 15142061)
21. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ
Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the efficacy of topical steroid and antibiotic combination therapy versus oral antibiotic alone when treating acute rhinosinusitis.
El-Hennawi DM; Ahmed MR; Farid AM; Al Murtadah AM
J Laryngol Otol; 2015 May; 129(5):462-7. PubMed ID: 25869467
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroid use does not alter nasal mucus glucose in chronic rhinosinusitis.
Hatten KM; Palmer JN; Lee RJ; Adappa ND; Kennedy DW; Cohen NA
Otolaryngol Head Neck Surg; 2015 Jun; 152(6):1140-4. PubMed ID: 25820586
[TBL] [Abstract][Full Text] [Related]
24. Aerosol distribution in the nose.
Mygind N; Vesterhauge S
Rhinology; 1978 Jun; 16(2):79-88. PubMed ID: 684327
[TBL] [Abstract][Full Text] [Related]
25. Reversible nasal airway obstruction: does change in nasal peak inspiratory flow following decongestion predict response to topical steroids in chronic rhinosinusitis patients?
Koo Ng NK; Young D; McGarry GW
J Laryngol Otol; 2012 Dec; 126(12):1238-40. PubMed ID: 23057871
[TBL] [Abstract][Full Text] [Related]
26. Influence of anatomy and head position on intranasal drug deposition.
Merkus P; Ebbens FA; Muller B; Fokkens WJ
Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):827-32. PubMed ID: 16807754
[TBL] [Abstract][Full Text] [Related]
27. Nasal and Olfactory Deposition with Normal and Bidirectional Intranasal Delivery Techniques: In Vitro Tests and Numerical Simulations.
Xi J; Wang Z; Nevorski D; White T; Zhou Y
J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):118-131. PubMed ID: 27977306
[TBL] [Abstract][Full Text] [Related]
28. Paranasal sinus exostoses: an unusual complication of topical drug delivery using cold nasal irrigations.
Haffey T; Woodard T; Sindwani R
Laryngoscope; 2012 Sep; 122(9):1893-7. PubMed ID: 22753257
[TBL] [Abstract][Full Text] [Related]
29. New medical management techniques for acute exacerbations of chronic rhinosinusitis.
Wahl KJ; Otsuji A
Curr Opin Otolaryngol Head Neck Surg; 2003 Feb; 11(1):27-32. PubMed ID: 14515098
[TBL] [Abstract][Full Text] [Related]
30. Recent trends in drug delivery systems: intranasal drug delivery.
Agarwal V; Mishra B
Indian J Exp Biol; 1999 Jan; 37(1):6-16. PubMed ID: 10355359
[TBL] [Abstract][Full Text] [Related]
31. A prospective, controlled study of SNS01 (ectoine nasal spray) compared to BNO-101 (phytotherapeutic dragées) in patients with acute rhinosinusitis.
Eichel A; Wittig J; Shah-Hosseini K; Mösges R
Curr Med Res Opin; 2013 Jul; 29(7):739-46. PubMed ID: 23621514
[TBL] [Abstract][Full Text] [Related]
32. Recent In Vitro and In Silico Advances in the Understanding of Intranasal Drug Delivery.
Chen J; Martin AR; Finlay WH
Curr Pharm Des; 2021; 27(12):1482-1497. PubMed ID: 33183191
[TBL] [Abstract][Full Text] [Related]
33. Drug delivery in the nasal cavity after functional endoscopic sinus surgery: a computational fluid dynamics study.
Chen XB; Lee HP; Chong VF; Wang DY
J Laryngol Otol; 2012 May; 126(5):487-94. PubMed ID: 22414292
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of particle deposition and penetration from nasal sprays.
Med Device Technol; 2004 Mar; 15(2):39. PubMed ID: 15154338
[No Abstract] [Full Text] [Related]
35. Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging.
Wingrove J; Swedrowska M; Scherließ R; Parry M; Ramjeeawon M; Taylor D; Gauthier G; Brown L; Amiel S; Zelaya F; Forbes B
J Control Release; 2019 May; 302():140-147. PubMed ID: 30953665
[TBL] [Abstract][Full Text] [Related]
36. Is topical antifungal therapy effective in the treatment of chronic rhinosinusitis?
Bush RK
J Allergy Clin Immunol; 2005 Jan; 115(1):123-4. PubMed ID: 15637557
[No Abstract] [Full Text] [Related]
37. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits.
Mullol J; Obando A; Pujols L; Alobid I
Immunol Allergy Clin North Am; 2009 Nov; 29(4):657-68. PubMed ID: 19879441
[TBL] [Abstract][Full Text] [Related]
38. Local drug delivery.
Harvey RJ; Schlosser RJ
Otolaryngol Clin North Am; 2009 Oct; 42(5):829-45, ix. PubMed ID: 19909862
[TBL] [Abstract][Full Text] [Related]
39. An endoscopic photographic comparison of nasal drug delivery by aqueous spray.
Homer JJ; Raine CH
Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):560-3. PubMed ID: 9884813
[TBL] [Abstract][Full Text] [Related]
40. Is nasal steroid spray bottle contamination a potential issue in chronic rhinosinusitis?
Tan NC; Drilling AJ; Jardeleza C; Wormald PJ
J Laryngol Otol; 2014 Jan; 128 Suppl 1():S28-33. PubMed ID: 23722019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
